Welcome to the ICU corridor
Explore interactive clinical cases based
on real-life clinician experiences of treating
patients at high risk of invasive fungal
infections (IFIs) within the Intensive Care
Unit (ICU) corridor.
on real-life clinician experiences of treating
patients at high risk of invasive fungal
infections (IFIs) within the Intensive Care
Unit (ICU) corridor.
Learn more about how and why treatment
decisions were made over time in response
to developing clinical scenarios.
decisions were made over time in response
to developing clinical scenarios.
Select a case study
Disclaimer:
If you have medical questions related to any Gilead’s, product, or
therapeutic area, please email: askGileadME@gilead.com Reporting
suspected adverse reactions of the medicinal products is important.
It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals and patients are asked to
report any suspected adverse via the national reporting scheme as
applicable. Adverse reactions may also be reported directly to the
manufacturer of the suspected product. Adverse reactions related to
Gilead products may be reported directly to Gilead via
Safety_FC@gilead.com
This material is for healthcare professionals practicing in the Middle
East region only.
therapeutic area, please email: askGileadME@gilead.com Reporting
suspected adverse reactions of the medicinal products is important.
It allows continued monitoring of the benefit/risk balance of the
medicinal product. Healthcare professionals and patients are asked to
report any suspected adverse via the national reporting scheme as
applicable. Adverse reactions may also be reported directly to the
manufacturer of the suspected product. Adverse reactions related to
Gilead products may be reported directly to Gilead via
Safety_FC@gilead.com
This material is for healthcare professionals practicing in the Middle
East region only.
Prepared June 2023
Job Code: SA-AMB-0083
